Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using high-throughput screening data to discriminate compounds with single-target effects from those with side

Justin Klekota1, Erik Brauner, Frederick P Roth

  • 1Howard Hughes Medical Institute, 12 Oxford Street, Cambridge, Massachusetts 02138, Harvard Institute of Chemistry and Cell Biology, 250 Longwood Avenue, SGMB-604, Boston, Massachusetts 02115, USA. Klekota@gmail.com

Journal of Chemical Information and Modeling
|July 25, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy.

Circulation·2026
Same author

Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effects.

Cell·2026
Same author

Global genetic interaction network of a human cell maps conserved principles and informs functional interpretation of gene co-essentiality profiles.

Cell·2026
Same author

Experimental assessment of AI-based interactome mapping.

Nature communications·2026
Same author

A scalable approach to resolving variants of uncertain significance.

bioRxiv : the preprint server for biology·2026
Same author

Mapping the Functional Landscape of <i>KCNQ1</i> to Define Ion Channel Mechanisms and Arrhythmia Risk.

medRxiv : the preprint server for health sciences·2025

Identifying single-target drug compounds is crucial for efficient drug discovery. This study introduces a new statistic, the coincidence score, to accurately identify compounds acting on a single biological target, reducing wasted resources on those with side effects.

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Pharmacology

Background:

  • High-throughput screening (HTS) identifies potential drug leads.
  • Compound leads with novel single-target biological activities are most desirable.
  • Identifying compounds with significant off-target effects (side effects) is a major challenge in drug discovery, leading to wasted resources.

Purpose of the Study:

  • To develop a method for identifying compound classes that primarily act on a single biological target.
  • To refine technical approaches for distinguishing single-target compounds from those with multiple off-target effects.

Main Methods:

  • Utilized multiple assays on a chemical library.
  • Developed and applied a novel statistic based on entropy, termed the coincidence score.

Related Experiment Videos

  • Analyzed patterns of assay activity to infer compound-target interactions.

    • Main Results:

    • The coincidence score accurately discriminated (88% accuracy) compound classes with primarily single-target effects from those with significant side effects on nonhomologous targets.
    • A notable proportion of compound classes predicted to have single-target effects included known bioactive compounds.
    • Demonstrated that a compound's activity pattern across multiple assays can suggest its biological target or mechanism of action.

    Conclusions:

    • The coincidence score is an effective metric for identifying promising single-target drug leads from HTS.
    • This approach can help conserve resources by prioritizing compounds with specific biological activities.
    • Assay activity patterns offer insights into predicting compound mechanisms of action and identifying potential drug targets.